4//SEC Filing
Wegman Toby 4
Accession 0001062993-18-003491
CIK 0000875622other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 7:48 PM ET
Size
5.3 KB
Accession
0001062993-18-003491
Insider Transaction Report
Form 4
Wegman Toby
Director10% Owner
Transactions
- Sale
Common Stock, $0.001 par value
2018-08-17$51.89/sh−2,500$129,728→ 947,473 total(indirect: See footnote)
Footnotes (2)
- [F1]The selling price of $51.8912 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.8641 to $52.00. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]These shares are held in trust on behalf of the reporting person and Mr. Thomas Wegman. The reporting person is the co-trustee of the trust with Mr. Thomas Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001405128
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 7:48 PM ET
- Size
- 5.3 KB